- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
International Journal of Alzheimer's Disease
Volume 2012 (2012), Article ID 376138, 17 pages
doi:10.1155/2012/376138
Vaccine Development to Treat Alzheimer’s Disease Neuropathology in APP/PS1 Transgenic Mice
1Department of Neurosciences, EuroEspes Biotechnology, Polígono de Bergondo, Nave F, 15165 A Coruña, Spain
2EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine and EuroEspes Foundation, 15166 La Coruña, Spain
3Neuroscience Division, Atlas Pharmaceuticals, Sunnyvale, CA 94089, USA
Received 15 May 2012; Revised 14 June 2012; Accepted 28 June 2012
Academic Editor: Francesco Panza
Copyright © 2012 Iván Carrera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Iván Carrera, Ignacio Etcheverría, Lucía Fernández-Novoa, Valter Lombardi, Ramón Cacabelos, and Carmen Vigo, “Vaccine Development to Treat Alzheimer’s Disease Neuropathology in APP/PS1 Transgenic Mice,” International Journal of Alzheimer's Disease, vol. 2012, Article ID 376138, 17 pages, 2012. doi:10.1155/2012/376138